Information was received from a healthcare provider (hcp) regarding a patient receiving morphine with an unknown dose and concentration via an implantable pump for non-malignant pain.It was reported via a clinical study the patient was diagnosed with a hardware infection at the pump pocket site.The patient presented on (b)(6) 2017 with incisional pain/swelling at the pump site.A seroma was noted and they were unable to aspirate/tried to aspirate but were unsuccessful on (b)(6) 2017.The pump was reprogrammed and the rate was increased on (b)(6) 2017.Examination on (b)(6) 2017 showed there was no signs/symptoms of infection.On (b)(6) 2017 it was reported the patient had/developed urinary tract infection symptoms, was seen by hcp, and labs were ordered.The results of the labs were unknown.On (b)(6) 2017 the patient reported having clear fluid leakage at the pump site noted at 10am (in the morning) per patient with abdominal pain only at the pump site (where pump was located).Examination on (b)(6) 2017 showed that there was a possible pump infection at the pump site, a broad spectrum of antibiotics were given, and the patient was admitted to the emergency room.Interventions included explanting (not replacing) the entire system on (b)(6) 2017 due to hardware infection.Examination on (b)(6) 2017 showed there was no signs/symptoms of infection.On (b)(6) 2017, the patient reported redness at the incision site with clear drainage.Medication, bactrim ds, was administered/prescribed on (b)(6) 2017.The event required in-patient or prolonged hospitalization.It was noted that the relationship of the event to the device or therapy was possible related, and the relationship of the event to the implant procedure was possibly related.The event was ongoing.No further complications were reported/anticipated.
|